ArticleSultan Qaboos University medical journal2024
Re: Efficacy and Safety of Vildagliptin and Remogliflozin as Add-on Therapy to Metformin in Patients of Type 2 Diabetes Mellitus.
Hunain Raza et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.